Singular Genomics Systems, Inc.·4

Aug 17, 4:31 PM ET

Ropp Sam 4

4 · Singular Genomics Systems, Inc. · Filed Aug 17, 2023

Insider Transaction Report

Form 4
Period: 2023-08-15
Ropp Sam
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-08-15+100,000100,000 total
    Exercise: $0.54Exp: 2033-08-14Common Stock (100,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2023-08-15+100,000100,000 total
    Exercise: $0.54Exp: 2033-08-14Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]The option shares vest and become exercisable in 48 equal monthly installments measured from August 15, 2023, subject to the Reporting Person's continuous service with the Issuer.
  • [F2]Subject to the achievement of certain performance targets by December 31, 2023, the Reporting Person may earn up to 100,000 stock options pursuant to this award. Any stock options earned will vest 25% on August 15, 2024, and the remaining option shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION